
About Strides Emerging Markets Limited
Data last updated:
Strides Emerging Markets Limited was a public limited company based in Bangalore, Karnataka, India, operated as a subsidiary of Strides Pharma (Cyprus) Limited, Cyprus. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 June 2012.
The company was registered with the Registrar of Companies (ROC), Bangalore, under CIN U24132KA2012PLC064214. Its GSTIN is 29AARCS5667D1ZQ (Karnataka).
The company had an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.63 Cr. It was formerly known as Strides Emerging Markets Private Limited. It was led by directors including Krishnan Tirucherai Parthasarathy and Venkata Seetharama Raju Pakalapati.
Its last annual general meeting (AGM) was held on 23 September 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at Strideshouse Bilekahalli Bannerghattaroad, Bangalore, Karnataka, India – 560076.
As per the financials filed for FY 2020, the company reported a revenue of ₹39.32 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹8.54 Cr (net margin 21.7%) and EBITDA of -₹5.55 Cr (EBITDA margin -14.1%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years.
The company had about 199 employees on its provident fund (EPFO) records before it was dissolved.
As per MCA filings, the company had satisfied charges of ₹15 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending.
The last known website on record is strides.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressStrideshouse Bilekahalli Bannerghattaroad, Bangalore, Karnataka, India – 560076
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Strides Emerging Markets Limited
The main business activity of Strides Emerging Markets is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Strides Emerging Markets Limited FY 2020 filings available
Strides Emerging Markets Limited reported revenue of ₹39.32 Cr (up 735% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR) of Strides Emerging Markets Limited
Revenue has grown at a compounded annual rate (CAGR) of 9% over three years, including 735% growth in the latest year. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Strides Emerging Markets Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹39.32 Cr | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹5.55 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.54 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Strides Emerging Markets Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -14.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 21.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Strides Emerging Markets are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Strides Emerging Markets Limited
Strides Emerging Markets Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stellar Formulations Industries Private Limited | ₹39.96 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Vadodara, Gujarat, India |
| Dolf Industries Private Limited | ₹39.95 Cr (FY 2025) | •••• | •••• | •••• | Dabhoi, Gujarat, India | |
| Zenith Enzymatic Drugs Private Limited | ₹39.93 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | Pune, Maharashtra, India |
| Vanelloid Private Limited | ₹39.6 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Ludhiana, Punjab, India |
| MMC Health Care Limited | ₹39.6 Cr (FY 2024) | •••• | •••• | -17.0% | •••• | Chennai, Tamil Nadu, India |
| Strides Emerging Markets Limited this company | ₹39.32 Cr (FY 2020) | •••• | •••• | 735.0% | •••• | Bangalore, Karnataka, India |
| Giyaan Pharma Private Limited | ₹39.31 Cr (FY 2024) | •••• | •••• | 16.0% | •••• | Hyderabad, Telangana, India |
| Embiotic Laboratories Private Limited | ₹39.29 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Bangalore, Karnataka, India |
| Forma Chem Pvt Ltd | ₹39.25 Cr (FY 2025) | •••• | •••• | -46.0% | •••• | Kolkata, West Bengal, India |
| Jo Pharma Limited | ₹39.24 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Delhi, India |
| Civentichem (India) Private Limited | ₹39.15 Cr (FY 2024) | •••• | •••• | -52.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Strides Emerging Markets by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Strides Emerging Markets Limited
Strides Emerging Markets Limited is audited by GNANOBA & BHAT for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GNANOBA & BHAT | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Strides Emerging Markets Limited
Strides Emerging Markets has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishnan Tirucherai Parthasarathy | Director | 30 Jan 2018 | 8 Years 8 Months | As last reported |
| Venkata Seetharama Raju Pakalapati | Director | 11 May 2016 | 10 Years 4 Months | As last reported |
| Umesh Pralhadrao Kale | Director | 11 May 2016 | 10 Years 4 Months | As last reported |
Ownership and Shareholding of Strides Emerging Markets Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Strides Emerging Markets Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Feb 2015 | Yes Bank Limited | ₹15 Cr | Satisfied |
Total charge records: 1 View all charges
Legal Cases of Strides Emerging Markets Limited
Strides Emerging Markets Limited has 2 court cases on record: 2 filed by Strides Emerging Markets. 1 case is pending and 1 is disposed. Status as checked on 28 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Court case (Com.EX.) | Filed by the company against Sri Ram Enterprises | Pending |
| District court, BENGALURU, Karnataka | Court case (Com.O.S.) | Filed by the company against Sri Ram Enterprises | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Strides Emerging Markets Limited
Strides Emerging Markets Limited has a workforce of 199 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Strides Emerging Markets Limited
Strides Emerging Markets has one previous CIN (Corporate Identification Number): U24132KA2012PTC064214. The current CIN is U24132KA2012PLC064214, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24132KA2012PLC064214 | Current |
| U24132KA2012PTC064214 | Previous |
News related to Strides Emerging Markets Limited
Recent Activity on Strides Emerging Markets Limited
Strides Emerging Markets Limited has 10 board changes on record since 2016: 3 appointments and 7 cessations. The latest: Akhilesh Kumar Balakrishna Pillai ceased to be Director on 29 Nov 2018.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Strides Emerging Markets Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Strides Emerging Markets Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Strides Emerging Markets Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Strides Emerging Markets Limited
Strides Emerging Markets has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AARCS5667D1ZQ | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Strides Emerging Markets Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Strides Emerging Markets Limited
Strides Emerging Markets has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Strides Emerging Markets was a public limited company based in Bangalore, Karnataka, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 01 June 2012 and is registered under CIN U24132KA2012PLC064214. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Strides Emerging Markets was incorporated on 01 June 2012. It is registered with the Registrar of Companies, Bangalore.
Strides Emerging Markets had 3 directors:
- Krishnan Tirucherai Parthasarathy - Director
- Venkata Seetharama Raju Pakalapati - Director
- Umesh Pralhadrao Kale - Director
The CIN (Corporate Identification Number) of Strides Emerging Markets is U24132KA2012PLC064214. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Strides Emerging Markets is at Strideshouse Bilekahalli Bannerghattaroad, Bangalore, Karnataka, India – 560076.
Strides Emerging Markets can be reached through the website strides.com. Its registered office is in Bangalore, Karnataka, India.
Strides Emerging Markets reported revenue of ₹39.32 Cr for FY 2020 (up 735% YoY).
Strides Emerging Markets has an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.63 Cr.
Strides Emerging Markets reported a net profit of ₹8.54 Cr (net margin 21.7%) and EBITDA of -₹5.55 Cr (EBITDA margin -14.1%) for FY 2020, as per its filed financial statements.
The GSTIN of Strides Emerging Markets is 29AARCS5667D1ZQ, registered in Karnataka.